Glen Burnie, Maryland Clinical Trials

A listing of Glen Burnie, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 64 clinical trials
EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression

This study will evaluate whether a lifestyle intervention focused on weight loss, EMPOWER, reduces prostate cancer progression at 12 months among men with biochemical recurrence following local treatment for prostate cancer. Half of the men will be randomized to receive the EMPOWER intervention, while the other half will receive standard …

ct scan
serum testosterone
tumor progression
testosterone level
metastasis
Johns Hopkins University
 (8.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

cns metastases
recurrent ewing sarcoma
recurrent melanoma
stem cell infusion
cns tumors
Johns Hopkins University/Sidney Kimmel Cancer Center
 (8.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +82 other locations
Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Subjects with Neurofibromatosis Type 2 (NF2) and progressive vestibular schwannoma (VS) will be treated with crizotinib administered orally. Crizotinib will be taken continuously until disease progression or unacceptable toxicity, in continuous treatment cycles of 28 days each, for a maximum of 12 cycles.

schwartz
neutrophil count
cataract
multiple meningiomas
neurofibroma
Johns Hopkins University (Site 250)
 (8.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +16 other locations
Early Bactericidal Activity of Standard Drugs Used to Treat Mycobacterium Avium Complex: a Pilot Study

To assess the early bactericidal activity of Azithromycin 250mg by mouth daily over the first 14 days of treatment for Mycobacterium avium complex (MAC) lung disease.

mycobacterium avium-intracellulare infection
azithromycin
mycobacterial infections
mycobacterium avium complex infection
pulmonary disease
Johns Hopkins University School of Medicine
 (9.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Ablation Versus Medical Management of Atrial Fibrillation in HFpEF

This is a prospective non-blinded randomized control pilot study comparing the effect of pulmonary vein isolation against medical management of atrial fibrillation in patients with Heart Failure with preserved Ejection Fraction (HFpEF).

heart disease
natriuretic peptide
diuretics
holter monitor
pro-brain natriuretic peptide
Johns Hopkins Hospital
 (8.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

This phase II trial studies how well infliximab and intravenous immunoglobulin therapy work in treating patients with pneumonitis that does not respond to steroid treatment. Immunotherapy with monoclonal antibodies such as, infliximab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow …

urine test
infliximab
sputum culture
antibody therapy
oophorectomy
Jarushka Naidoo
 (7.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study to Evaluate Efficacy and Safety of PTC299 in Hospitalized Participants With Coronavirus (COVID-19)

This is a randomized, double-blind, placebo-controlled, multicenter, 28-day study of adult participants hospitalized with COVID-19, with a safety follow-up telephone call at Day 60.

x-rays
ct scan
acute respiratory syndrome (sars)
fever
vasectomy
Johns Hopkins Hospital
 (8.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +4 other locations
Intravesical Gemcitabine and Docetaxel for BCG na ve Non-muscle Invasive Bladder Cancer

A single-arm, two-stage, open-label, phase 2 study investigating the safety and efficacy of intravesical gemcitabine/docetaxel for bacillus Calmette-Guerin (BCG)-nave patients with non-muscle invasive bladder cancer (NMIBC). All participants will receive an induction course of gemcitabine/docetaxel instillations followed by maintenance instillations if initial efficacy is seen. In addition to providing initial …

bilateral salpingectomy
bacillus calmette-guerin
hormone levels
intravesical bcg therapy
invasive bladder cancer
Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center
 (8.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

antiandrogen therapy
antiandrogens
cancer
testosterone
prostatic neoplasms, castration-resistant
Johns Hopkins University
 (8.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +21 other locations
Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD)

A naturalistic study design, in which dTMS patients will be randomized to get a free add-on CBT treatment. The dTMS procedure will include treatment as usual, and participants will use the app from post randomization (Pre-treatment is defined as measures from the first three days of treatment) to the end …

Greenbrook - Glen Burnie
 (2.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +21 other locations